229 related articles for article (PubMed ID: 17388739)
1. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
Vaidya D; Kelemen MD; Bittner V; Tardif JC; Thompson P; Ouyang P
J Womens Health (Larchmt); 2007 Mar; 16(2):228-34. PubMed ID: 17388739
[TBL] [Abstract][Full Text] [Related]
2. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
[TBL] [Abstract][Full Text] [Related]
3. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study.
Arcavi L; Behar S; Caspi A; Reshef N; Boyko V; Knobler H
Am Heart J; 2004 Feb; 147(2):239-45. PubMed ID: 14760320
[TBL] [Abstract][Full Text] [Related]
4. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women.
Mellen PB; Cefalu WT; Herrington DM
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):189-93. PubMed ID: 16239594
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
[TBL] [Abstract][Full Text] [Related]
7. Racial differences of lipoprotein subclass distributions in postmenopausal women.
Vora AN; Ouyang P; Bittner V; Tardif JC; Waters DD; Vaidya D
Ethn Dis; 2008; 18(2):176-80. PubMed ID: 18507270
[TBL] [Abstract][Full Text] [Related]
8. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
11. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M
J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes.
Rivero K; Portal VL; Vieira M; Behle I
Diabetes Res Clin Pract; 2008 Mar; 79(3):433-7. PubMed ID: 18045723
[TBL] [Abstract][Full Text] [Related]
14. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Lenzen M; Ryden L; Ohrvik J; Bartnik M; Malmberg K; Scholte Op Reimer W; Simoons ML;
Eur Heart J; 2006 Dec; 27(24):2969-74. PubMed ID: 17090612
[TBL] [Abstract][Full Text] [Related]
15. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
[TBL] [Abstract][Full Text] [Related]
16. Obesity, estrone, and coronary artery disease in postmenopausal women.
Silva TC; Barrett-Connor E; Ramires JA; Mansur AP
Maturitas; 2008 Mar; 59(3):242-8. PubMed ID: 18374526
[TBL] [Abstract][Full Text] [Related]
17. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
[TBL] [Abstract][Full Text] [Related]
18. [Association between fasting plasma glucose and the 5 years outcome post PCI in aged patients with coronary artery disease].
Su HY; Pan CY; Liu M; Jin MM
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):710-3. PubMed ID: 19100112
[TBL] [Abstract][Full Text] [Related]
19. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
[TBL] [Abstract][Full Text] [Related]
20. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.
Otsuki M; Kasayama S; Morita S; Asanuma N; Saito H; Mukai M; Koga M
Menopause; 2007; 14(3 Pt 1):404-7. PubMed ID: 17213751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
